Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) started the day on January 19, 2021, with a price decrease of -7.96% at $1.04. During the day, the stock rose to $1.09 and sunk to $1.01 before settling in for the price of $1.13 at the close. Taking a more long-term approach, DFFN posted a 52-week range of $0.25-$1.60.
Meanwhile, its Annual Earning per share during the time was 58.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 78.90%. This publicly-traded company’s shares outstanding now amounts to $64.01 million, simultaneously with a float of $63.88 million. The organization now has a market capitalization sitting at $68.93 million. At the time of writing, stock’s 50-day Moving Average stood at $0.8096, while the 200-day Moving Average is $0.8838.
Diffusion Pharmaceuticals Inc. (DFFN) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Diffusion Pharmaceuticals Inc.’s current insider ownership accounts for 0.10%, in contrast to 10.70% institutional ownership. According to the most recent insider trade that took place on Nov 17, this organization’s GC & Secretary bought 5,000 shares at the rate of 0.63, making the entire transaction reach 3,150 in total value, affecting insider ownership by 15,000. Preceding that transaction, on Nov 16, Company’s President & CEO bought 14,000 for 0.66, making the whole transaction’s value amount to 9,240. This particular insider is now the holder of 14,000 in total.
Diffusion Pharmaceuticals Inc. (DFFN) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2020, the organization reported -$0.07 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.05) by -$0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
Diffusion Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 78.90% and is forecasted to reach -0.23 in the upcoming year.
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) Trading Performance Indicators
Let’s observe the current performance indicators for Diffusion Pharmaceuticals Inc. (DFFN). It’s Quick Ratio in the last reported quarter now stands at 8.40. The Stock has managed to achieve an average true range (ATR) of 0.12.
In the same vein, DFFN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.50, a figure that is expected to reach -0.06 in the next quarter, and analysts are predicting that it will be -0.23 at the market close of one year from today.
Technical Analysis of Diffusion Pharmaceuticals Inc. (DFFN)
If we take a close look at the recent performances of Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN), its last 5-days Average volume was 4.28 million that shows plunge from its year to date volume of 4.97 million. During the previous 9 days, stock’s Stochastic %D was recorded 40.17% While, its Average True Range was 0.1391.
Raw Stochastic average of Diffusion Pharmaceuticals Inc. (DFFN) in the period of the previous 100 days is set at 51.02%, which indicates a major rise in contrast to 40.57% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 187.01% that was higher than 94.61% volatility it exhibited in the past 100-days period.